The global inflammatory bowel disease treatment market was estimated to be worth US$19.3 billion in 2021. The market is anticipated to reach a valuation of around US$ 35.1 billion by the end of 2032, with a projected compound annual growth rate (CAGR) of 5.7% between 2022 and 2032. This rise is attributed to increased global spending on …